Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Booster on Coronavirus Disease 2019 (COVID-19) Symptom Severity Over Time in the COVID-OUT Trial

By sjmartinez • February 11, 2023

Boulware DR, Murray TA, Proper JL, Tignanelli CJ, Buse JB, Liebovitz DM, Nicklas JM, Cohen K, Puskarich MA, Belani HK, Siegel LK, Klatt NR, Odde DJ, Karger AB, Ingraham NE, Hartman KM, Rao V, Hagen AA, Patel B, Fenno SL, Avula N, Reddy NV, Erickson SM, Lindberg S, Fricton R, Lee S, Zaman A, Saveraid HG, Tordsen WJ, Pullen MF, Sherwood NE, Huling JD, Bramante CT; COVID-OUT study team. Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Booster on Coronavirus Disease 2019 (COVID-19) Symptom Severity Over Time in the COVID-OUT Trial. Clin Infect Dis. 2023 Feb 8;76(3):e1-e9. doi: 10.1093/cid/ciac772. PMID: 36124697; PMCID: PMC9494422.

Tags: covid-19, General Internal Medicine, Olive View DoM, Publications, SARS-CoV-2, Symptoms, vaccine

Development and Performance of the National Child Traumatic Stress Network Trauma-Informed Organizational Assessment

Purbeck CA, Liang LJ, Glazkova L, Agosti J, Liu JH, Halladay Goldman J. Development and Performance of the National Child Traumatic Stress Network Trauma-Informed Organizational[...]

Reprogramming Immunosuppressive Niches and the Cancer Immunity Cycle in Pancreatic Cancer with Neoantigen mRNA Plus Immune Adjuvant Nanocarrier Strategies

Nel AE, Luo L, Liao YP, Wang X. Reprogramming Immunosuppressive Niches and the Cancer Immunity Cycle in Pancreatic Cancer with Neoantigen mRNA Plus Immune Adjuvant[...]

Hemodynamic data reporting and group separation: Key to interpreting individualized blood pressure trials

Delaporte A, Bahrun E, Lin K, Grogan T, Joosten A. Hemodynamic data reporting and group separation: Key to interpreting individualized blood pressure trials. J Clin[...]